[PAGID] Cellcept for ITP and CVID

Chris Seroogy cmseroogy at pediatrics.wisc.edu
Wed May 7 14:44:47 EDT 2008


Dear Mel,

375 mg/m2 weekly x 4. Her spleen is normal in size per physical exam.
Chris


On 5/7/08 1:34 PM, "Berger, Melvin" <Melvin.Berger at UHhospitals.org> wrote:


> You don't give details, but have you tred pushing the dose of Rituxin ? We

> have had very good success with Rituxin in CVID patients with cytopenia. Since

> they are already on IGIV we don't worry so much about it having adverse effecs

> on protective antibody responses.

>

> Does the patient have a big spleen ?

>

> Mel Berger

>

> -----Original Message-----

> From: pagid-bounces at list.clinimmsoc.org

> [mailto:pagid-bounces at list.clinimmsoc.org] On Behalf Of Chris Seroogy

> Sent: Wednesday, May 07, 2008 11:46 AM

> To: pagid at list.clinimmsoc.org

> Subject: [PAGID] Cellcept for ITP and CVID

>

> Hello,

>

> Has anyone had success using cellcept for ITP in CVID patients? I have a

> teenager who presented a number of years ago with ITP and AIHA. She

> fulfills the criteria for CVID and is on IVIG. She had a recent flare in

> her ITP and failed increasing her IVIG. She was started on prednisone and

> rituxan. She just finished her fourth cycle of rituxan and is tapering on

> her prednisone. She responded nicely (I think more to the steroids than the

> rituxan since the response was early and rapid) but now her platelets are

> slowly dropping. As opposed to offering splenectomy, I was thinking of

> cellcept since I think the risk/benefit is better in general. Thank you for

> sharing your experiences. Chris

>

>

> Chris Seroogy, M.D.

>

> University of Wisconsin

>

> Assistant Professor

>

> Dept. of Pediatrics

>

> Mail:  H4/474 CSC, Mailstop 4108

>

> Shipping:  H4/431 CSC, Mailstop 4108

>

> 600 Highland Ave.

>

> Madison, WI  53792

>

> phone: 608- 263-2652

>

> fax: 608-265-0164

>

> The information in this message (and the documents attached to it, if

>

> any) is confidential and may be legally privileged. It is intended

>

> solely for the addressee. Access to this message by anyone else is

>

> unauthorized. If you are not the intended recipient, any disclosure,

>

> copying, distribution or any action taken, or omitted to be taken in

>

> reliance on it is prohibited and may be unlawful. If you have received

>

> this message in error, please delete all electronic copies of this

>

> message (and the documents attached to it, if any), destroy any hard

>

> copies you may have created and notify me immediately by replying to

>

> this email. Thank you.

>

>

>

>

>

> Visit us at www.UHhospitals.org.

>

> The enclosed information is STRICTLY CONFIDENTIAL and is intended for the use

> of the addressee only. University Hospitals and its affiliates disclaim any

> responsibility for unauthorized disclosure of this information to anyone other

> than the addressee.

>

> Federal and Ohio law protect patient medical information, including

> psychiatric_disorders, (H.I.V) test results, A.I.Ds-related conditions,

> alcohol, and/or drug_dependence or abuse disclosed in this email. Federal

> regulation (42 CFR Part 2) and Ohio Revised Code section 5122.31 and 3701.243

> prohibit disclosure of this information without the specific written consent

> of the person to whom it pertains, or as otherwise permitted by law.




More information about the PAGID mailing list